The combined effect on gastric emptying could increase gastrointestinal side effects, and there is no clinical data on the safety of combining GLP-1 Complete specifically with semaglutide or tirzepatide
1C,D), suggesting underlying tumor heterogeneity at play, and that the GPX4 and TfR1 basal expressions may not serve as reliable markers in vitro
Rubin, L.L., Gatchalian, C.L., Rimon, G
Alternatively, finding that the proportion of patients using antihypertensive medications and the distribution of different antihypertensive agents (and of their different combinations) were comparable between groups can be taken to suggest that data were very unlikely confounded by concomitant BP-lowering therapy, even if it was not standardized
doi: 10.1016/j.pharmthera.2007.06.008 72 BarbaraGStanghelliniVDe GiorgioRCremonCCottrellGSSantiniDet al